Skip to main content

$0.028 (0%)

High

$0.03

Low

$0.03

Trades

3

Turnover

$1,185

Volume

42,322
30 June 2023 at 12:13pm
Register to track ANR and receive email alerts.
Subject
ANR Ann: R&D Tax Refund Received

ANR Ann: 3FDC Clinical Trial update

ANR Ann: Annual General Meeting & Director Nominations

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Appendix 4E & Audited Financial Report 30 June 2022

ANR Ann: Operational Update

ANR Ann: Q4 FY22 Activities Report

ANR Ann: Quarterly Appendix 4C Cash Flow Report

ANR Ann: Notification of cessation of securities - ANR

ANR Ann: Notification of cessation of securities - ANR

ANR Ann: Notification of cessation of securities - ANR

ANR Ann: Notification of cessation of securities - ANR

ANR Ann: Clinical Trial and Operational Update

ANR Ann: Clinical Trial and Operational Update

ANR Ann: Anatara Lifesciences announces leadership change

ANR Ann: Appendix 4C and Q3 FY22 Activities Report

ANR Ann: Clinical Trials Update

ANR Ann: Half Year Accounts

ANR Ann: Clinical Trials Update

ANR Ann: Appendix 4C and Q2 FY22 Activities Report

ANR Ann: Appendix 4C and Q2 FY22 Activities Report

ANR Ann: Clinical Trials Update

ANR Ann: Change of Director's Interest Notice

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Application for quotation of securities - ANR

ANR Ann: Anatara Strengthens the Team with New Appointments

ANR Ann: Results of Meeting

ANR Ann: AGM CEO Presentation

ANR Ann: Chairman's Address to Shareholders

ANR Ann: Appendix 2A

ANR Ann: Appendix 4C & Q1 FY22 Activities Report

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Notification of cessation of securities - ANR

ANR Ann: Notification of cessation of securities - ANR

ANR Ann: Appendix 4G and Corporate Governance Statement

ANR Ann: Annual Report to shareholders

ANR Ann: Notice of Annual General Meeting/Proxy Form

ANR Ann: Annual General Meeting & Director Nominations

ANR Ann: Change of Director's Interest Notice

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Meet the CEO Investor Webinar

ANR Ann: Investor Presentation

ANR Ann: Application for quotation of securities - ANR

ANR Ann: Appendix 4E & Financial Report 30 June 2021

ANR Ann: Anatara launches IBS-D Clinical Trial recruitment website

ANR Ann: Notification regarding unquoted securities - ANR

ANR Ann: Application for quotation of securities - ANR

ANR Ann: Successful Piglet Study

Register to track ANR and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX